Subsequent therapies post-afatinib among patients (pts) with EGFR mutation-positive (EGFRm plus ) NSCLC in LUX-Lung (LL) 3, 6 and 7Lecia V. Sequist,Y-L. Wu, M. Schuler,T. Kato,J. C-H. Yang,H. Tanaka,T. Hida,Shun Lu,K. Park,Scott A. Laurie,J. Bennouna,D. Moro Sibilot,A. Märten, B. Peil,E. Ehrnrooth,Nobuyuki Yamamoto,Kazuhiko NakagawaANNALS OF ONCOLOGY(2017)引用 22|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要